Detalhe da pesquisa
1.
MOLECULAR PATHWAYS OF COLORECTAL CANCER DEVELOPMENT: MECHANISMS OF ACTION AND EVOLUTION OF MAIN SYSTEMIC THERAPY COMPOUNDS.
Dig Dis
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531339
2.
Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study.
Dig Dis
; 40(4): 517-525, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515093
3.
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.
Oncologist
; 16(1): 53-60, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21212430
4.
Seminoma Retroperitoneal Relapse 23 Years After Surgery.
Oncol Ther
; 9(1): 239-245, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606194
5.
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.
Int J Cancer
; 127(8): 1941-7, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20099280
6.
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review.
Oncol Ther
; 8(1): 147-160, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700070
7.
Chronic non-allergic rhinitis with neutrophils is associated with higher acid exposure time: A pH-impedance monitoring study.
Dig Liver Dis
; 52(4): 414-419, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31874835
8.
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
BMC Cancer
; 9: 303, 2009 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19712476
9.
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.
Lancet Oncol
; 9(1): 39-44, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18077217
10.
Pancreatic cancer: progress in cancer therapy.
Crit Rev Oncol Hematol
; 67(1): 27-38, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18356073
11.
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors.
Dig Liver Dis
; 49(10): 1128-1132, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28625406
12.
Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies.
Radiother Oncol
; 122(3): 332-339, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28104297
13.
Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.
Tumori
; 92(5): 384-8, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17168429
14.
Prediction of the Risk of Lymph Node Metastases in Early Gastric Cancer: Contrast-Enhanced Harmonic Endoscopic Ultrasonography May Help.
Gut Liver
; 15(6): 940-941, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140430
15.
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.
Cell Adh Migr
; 9(1-2): 14-21, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25562532
16.
State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review.
Crit Rev Oncol Hematol
; 88(1): 75-86, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23522920
17.
Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome.
Dig Liver Dis
; 45(1): 70-4, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22999058
18.
Role of maspin in cancer.
Clin Transl Med
; 2(1): 8, 2013 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497644
19.
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
Onco Targets Ther
; 6: 563-76, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23723712
20.
Maspin expression is a favorable prognostic factor in non-small cell lung cancer.
Anal Quant Cytol Histol
; 34(2): 72-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611762